Physician profile
Islam Abbassi
NPI 1144886441
$3,512.90
in general payments reported to CMS, 2019-2025
18 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $227 · 2024: $1,808 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809 · Travel and Lodging: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,808.92 |
| Travel and Lodging | $1,703.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,391.19 | 2024 | Monkey Rings, Phantom Intramedullary Nail |
| Stryker Corporation | $1,117.93 | 2024-2025 | Hoffmann, Prostep Mica, Citrefix |
| Kerecis Limited | $248.14 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $247.73 | 2024-2025 | Integra, Tcc-Ez, Primatrix |
| Amgen INC. | $82.80 | 2024-2025 | Krystexxa |
| Axogen | $68.91 | 2025 | |
| Treace Medical Concepts, INC. | $62.45 | 2024 | |
| Acera Surgical, INC. | $49.41 | 2024-2025 | Restrata Wound Matrix |
| Bioventus LLC | $43.05 | 2023 | Sonicone Clinic |
| Solventum Corporation | $33.94 | 2024-2025 | V.A.C.Ulta, V.A.C. Veraflo |
| Paratek Pharmaceuticals, INC. | $33.81 | 2023-2024 | Nuzyra |
| Smith+Nephew, INC. | $33.20 | 2023-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Collagenase Santyl |
| Averitas Pharma INC. | $19.15 | 2025 | Qutenza |
| Linvatec Corporation | $18.43 | 2025 | Biobrace 23mm |
| Dynasplint Systems INC. | $17.48 | 2025 | Dynasplint |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $15.85 | 2025 | Apligraf |
| Seapearl East, INC | $15.60 | 2024 | |
| Convatec INC. | $13.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Islam Abbassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.